(2aR,3S,4R,5aS,5bS,7aR,9S,11aR,12aS)-2a,5a-dimethyl-9-(methylamino)-3-((S)-1-(methylamino)ethyl)-8-methylenehexadecahydrocyclopenta[a]cyclopropa[e]phenanthren-4-ol; 9,19-Cyclo-5-alpha,9-beta-pregnan-16-alpha-ol, 14-methyl-3-beta,20-alpha-bis(methylamino)-4-methylene-;9, 14-methyl-3,20-bis(methylamino)-4-methylene-, (3.beta.,5.alpha.,16.alpha.,20S)-;9,19-Cyclo-5alpha,9beta-pregnan-16alpha-ol, 14-methyl-3beta,20alpha-bis(methylamino)-4-methylene- (8CI);9,19-Cyclopregnan-16-ol, 14-methyl-3,20-bis(methylamino)-4-methylene-, (3beta,5alpha,16alpha,20S)- (9CI);9,9.beta.-pregnan-16.alpha.-ol, 14-methyl-3.beta.,20.alpha.-bis(methylamino)-4-methylene-
Cyclobuxine D is a fully characterized chemical compound used as a reference standard of API Cyclobuxine. The standard offered is compliant with regulatory guidelines. Cyclobuxine D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 2241-90-9
